124 related articles for article (PubMed ID: 323739)
21. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Gutiérrez C
Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
[No Abstract] [Full Text] [Related]
22. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
Teruel JL; Marcen R; Navarro-Antolin J; Aguilera A; Fernandez-Juarez G; Ortuño J
J Am Soc Nephrol; 1996 Jan; 7(1):140-4. PubMed ID: 8808121
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure after three different forms of correction of anemia in hemodialysis.
Pascual J; Teruel JL; Marcén R; Liaño F; Ortuño J
Int J Artif Organs; 1992 Jul; 15(7):393-6. PubMed ID: 1516988
[TBL] [Abstract][Full Text] [Related]
24. A comparison of androgens for anemia in patients on hemodialysis.
Neff MS; Goldberg J; Slifkin RF; Eiser AR; Calamia V; Kaplan M; Baez A; Gupta S; Mattoo N
N Engl J Med; 1981 Apr; 304(15):871-5. PubMed ID: 7010161
[TBL] [Abstract][Full Text] [Related]
25. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
[TBL] [Abstract][Full Text] [Related]
26. Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease.
Paul AK; Latif ZA; Iqbal S; Amin F; Shefin SM; Ashrafuzzaman SM
Mymensingh Med J; 2012 Jan; 21(1):125-8. PubMed ID: 22314467
[TBL] [Abstract][Full Text] [Related]
27. A controlled trial of nondrolone decanoate in the treatment of uremic anemia.
Cattran DC; Fenton SS; Wilson DR; Oreopoulos D; Shimizu A; Richardson RM
Kidney Int; 1977 Dec; 12(6):430-7. PubMed ID: 609193
[TBL] [Abstract][Full Text] [Related]
28. [Advances in therapy of renal anemia: darbepoetin alfa].
Schaefer R
Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
[No Abstract] [Full Text] [Related]
29. Circulating levels of thrombopoietin and erythropoietin in hemodialysis patients.
Otsubo Y; Nitta K; Otsubo S; Kimata N; Miwa N; Watanabe Y; Uchida K; Kawashima A; Yumura W; Akiba T; Nihei H
Acta Haematol; 2003; 109(4):209-11. PubMed ID: 12853697
[No Abstract] [Full Text] [Related]
30. Anabolic steroids in severe chronic renal failure.
Malhotra KK; Suresh KR; Bansal RC
J Assoc Physicians India; 1984 Oct; 32(10):878-80. PubMed ID: 6394584
[No Abstract] [Full Text] [Related]
31. Letter: Hemodialysis statistics anemic?
Goodman J; Bessman AN
N Engl J Med; 1975 Jan; 292(5):264. PubMed ID: 1110697
[No Abstract] [Full Text] [Related]
32. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
[TBL] [Abstract][Full Text] [Related]
33. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
Mora C; Macía ML; García J; Navarro JF
Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
[No Abstract] [Full Text] [Related]
34. Effect of low doses of recombinant human erythropoietin on the anemia in hemodialyzed patients.
Okada K; Takahashi S
Nephron; 1991; 59(4):689-90. PubMed ID: 1766524
[No Abstract] [Full Text] [Related]
35. Subcutaneous erythropoietin in the treatment of renal anaemia.
Drinovec J; Varl J
Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
[TBL] [Abstract][Full Text] [Related]
36. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
[TBL] [Abstract][Full Text] [Related]
37. Nandrolone decanoate may be an adjuvant therapy to augment haemoglobin response today?
Gascón A; Bélvis JJ; Berisa F; Iglesias E
Nephrol Dial Transplant; 1999 Sep; 14(9):2257-8. PubMed ID: 10489248
[No Abstract] [Full Text] [Related]
38. Hemoglobin levels, quality of life, and survival.
Sadler JH; Meyer KB
Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
[No Abstract] [Full Text] [Related]
39. Prospective controlled study of androgen therapy in the anemia of chronic renal disease: effects on iron kinetics.
Solomon LR; Hendler ED
Acta Haematol; 1988; 79(1):12-9. PubMed ID: 3124456
[TBL] [Abstract][Full Text] [Related]
40. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
